<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Healthcare industry BW</title>
    <description>Healthcare industry BW</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://www.gesundheitsindustrie-bw.de/en</link>
    <item>
      <title>Match Arena</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Tue, 13 Oct 2026 11:19:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/match-arena-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/match-arena-en</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>High iron levels may promote the mobility of brain tumor cells</title>
      <description><![CDATA[Iron is essential for healthy cells. Cancer cells also require this trace element. Researchers in Freiburg have now found evidence that high levels of iron directly in the tumor microenvironment promote the spread of certain cells in a particularly aggressive type of brain tumor known as glioblastoma. In the long term, iron metabolism could therefore serve as a target for more precisely influencing particularly invasive tumor cells.]]></description>
      <pubDate>Thu, 08 Oct 2026 07:38:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/high-iron-levels-may-promote-mobility-brain-tumor-cells</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/high-iron-levels-may-promote-mobility-brain-tumor-cells</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>The Freiburg-based start-up Glassomer is rethinking materials</title>
      <description><![CDATA[Glassomer has developed an innovative process for producing pure quartz glass. The result is geometrically complex glass components with micrometre-level precision that can be reproduced consistently at a fraction of the energy cost of conventional glass-melting processes. The company focuses in particular on customised products for diagnostic, therapeutic and microfluidic applications.]]></description>
      <pubDate>Wed, 07 Oct 2026 09:19:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/news/freiburg-based-start-glassomer-rethinking-materials</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/news/freiburg-based-start-glassomer-rethinking-materials</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>EXIST funding for xenko start-up team at Ulm University Virtual health platform to encourage more physical activity in the working day</title>
      <description><![CDATA[The start-up xenko has been awarded an EXIST grant of 143,500 € from the Federal Ministry for Economic Affairs and Energy. The team of founders from Ulm University is developing a digital health platform designed to encourage more physical activity in everyday working life through virtual reality. This development is of interest to companies with occupational health management schemes and, in the long term, to the physiotherapy sector as well.]]></description>
      <pubDate>Tue, 06 Oct 2026 14:42:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/exist-funding-xenko-start-team-ulm-university-virtual-health-platform-encourage-more-physical-activity-working-day</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/exist-funding-xenko-start-team-ulm-university-virtual-health-platform-encourage-more-physical-activity-working-day</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Harnessing Synthetic Cellular Systems as Immune Cell Boosters</title>
      <description><![CDATA[How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies.]]></description>
      <pubDate>Tue, 06 Oct 2026 09:57:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/harnessing-synthetic-cellular-systems-immune-cell-boosters</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/harnessing-synthetic-cellular-systems-immune-cell-boosters</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer</title>
      <description><![CDATA[CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking.]]></description>
      <pubDate>Mon, 05 Oct 2026 10:41:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer-1</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer-1</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer</title>
      <description><![CDATA[CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking.]]></description>
      <pubDate>Mon, 05 Oct 2026 07:55:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>How blood flow controls liver function</title>
      <description><![CDATA[The liver is organized into distinct zones in which liver cells perform different functions. The blood vessels of the liver play an important role in this spatial organization: the endothelial cells lining the vessels provide signals that instruct neighboring liver cells and help determine their function. But how do endothelial cells know which signals to produce?]]></description>
      <pubDate>Mon, 05 Oct 2026 07:46:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-blood-flow-controls-liver-function</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-blood-flow-controls-liver-function</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Aktuelle Trends im Biomanufacturing – Erfolgsmodell Kooperation</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Mon, 05 Oct 2026 06:49:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/aktuelle-trends-im-biomanufacturing-erfolgsmodell-kooperation-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/aktuelle-trends-im-biomanufacturing-erfolgsmodell-kooperation-en</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>DMEA 2027</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Thu, 01 Oct 2026 15:07:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/dmea-2027-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/dmea-2027-en</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>New AI Agent to Capture and Analyze Patient Experiences for Healthcare Delivery and Health Systems</title>
      <description><![CDATA[An international consortium led by researchers at the Heidelberg Faculty of Medicine at Heidelberg University will develop an AI-powered interactive assistant for the analysis of patient experiences over the next four years. The goal is to identify individual burdens and challenges early and comprehensively and make this information actionable for patients, care teams, and health systems.]]></description>
      <pubDate>Thu, 01 Oct 2026 13:40:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-ai-agent-capture-and-analyze-patient-experiences-healthcare-delivery-and-health-systems</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-ai-agent-capture-and-analyze-patient-experiences-healthcare-delivery-and-health-systems</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>How cells pass on regulatory information</title>
      <description><![CDATA[A project funded by the Baden-Württemberg Stiftung at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg is investigating the interplay between RNA modifications and epigenetic mechanisms during cell division – and its potential significance for treatment resistance in cancer.]]></description>
      <pubDate>Wed, 30 Sep 2026 07:31:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-cells-pass-regulatory-information</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-cells-pass-regulatory-information</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Heidelberg University with Top Placings in latest Shanghai Subject Ranking</title>
      <description><![CDATA[With clinical medicine and medical technology Heidelberg University is again among the best players in Medical Sciences worldwide. In the Global Ranking of Academic Subjects 2026 clinical medicine rose by one place over last year to rank 17th internationally in clinical medicine and so leads the field in Germany. Medical technology is in 21st place internationally and continues to be ranked third in Germany. ]]></description>
      <pubDate>Fri, 25 Sep 2026 17:48:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-university-top-placings-latest-shanghai-subject-ranking</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-university-top-placings-latest-shanghai-subject-ranking</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Enzyme Beads for More Sustainable Chemistry</title>
      <description><![CDATA[Thanks to enzyme-based biocatalysis, an enormous range of pharmaceutical active ingredients and other complex molecules can be synthesized in an environmentally friendly manner. Researchers at the Karlsruhe Institute of Technology (KIT) have now developed a technology that allows to assemble enzymes into millimeter-sized, storable beads. In this process, the enzymes not only act as catalysts but also constitute the beads’ material itself.]]></description>
      <pubDate>Thu, 24 Sep 2026 06:40:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/enzyme-beads-more-sustainable-chemistry</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/enzyme-beads-more-sustainable-chemistry</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>ViferaXS Raises €12 Million to Advance Phase II Trial in Chronic Lymphocytic Leukemia and Expand Its Oncology Pipeline</title>
      <description><![CDATA[ViferaXS, a clinical-stage biotechnology company developing peptide-based cancer immunotherapy for hematologic malignancies and solid tumors, today announced the close of the Series A financing round of up to €12 million, including grant funding. The round was led by SPRIND, the German Federal Agency for Breakthrough Innovation, and Huma, with participation from private investors.]]></description>
      <pubDate>Wed, 23 Sep 2026 14:11:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/viferaxs-raises-euro-12-million-advance-phase-ii-trial-chronic-lymphocytic-leukemia-and-expand-its-oncology-pipeline</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/viferaxs-raises-euro-12-million-advance-phase-ii-trial-chronic-lymphocytic-leukemia-and-expand-its-oncology-pipeline</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>The digital twin – shaping the future of neonatal medicine</title>
      <description><![CDATA[Virtually every newborn undergoes routine screening shortly after birth to detect congenital disorders. These examinations have generated a unique wealth of data on early childhood development. However, for many years this valuable resource remained largely untapped. That all changed when researchers in Heidelberg started to use the data to develop a digital twin for newborns. Today, the technology is on the verge of entering clinical practice.]]></description>
      <pubDate>Tue, 22 Sep 2026 07:00:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/news/digital-twin-shaping-future-neonatal-medicine</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/news/digital-twin-shaping-future-neonatal-medicine</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>New technique could make MRI more precise</title>
      <description><![CDATA[A team of researchers at the University of Stuttgart has developed a new method that could make MRI even more precise by eliminating “dead time,” a key limiting factor in the measurement process, thereby enabling the detection of signals that are lost using conventional methods. This method opens up new possibilities for medical diagnostics and non-destructive materials testing. The research team presents the new approach in Science Advances.]]></description>
      <pubDate>Thu, 17 Sep 2026 07:35:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-technique-could-make-mri-more-precise</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-technique-could-make-mri-more-precise</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Introduction to Planetary Protection</title>
      <description><![CDATA[Kein Inhalt]]></description>
      <pubDate>Thu, 17 Sep 2026 06:58:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/event/introduction-planetary-protection-en</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/event/introduction-planetary-protection-en</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Professor Jakob Nikolas Kather Appointed Hopp Foundation Professor of “Artificial Intelligence in Medicine” and Founding Director of the New Institute for Medical AI (IMAI) in Heidelberg</title>
      <description><![CDATA[Effective 1 October 2026, Professor Jakob Nikolas Kather will assume the Hopp Foundation Professorship for “Artificial Intelligence in Medicine” at the Heidelberg Faculty of Medicine at Heidelberg University. Associated with the professorship is the establishment of the new Institute for Medical AI (IMAI) at Heidelberg University Hospital, which Professor Kather will lead as its founding director.]]></description>
      <pubDate>Wed, 16 Sep 2026 15:15:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/professor-jakob-nikolas-kather-appointed-hopp-foundation-professor-artificial-intelligence-medicine-and-founding-director-new-in</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/professor-jakob-nikolas-kather-appointed-hopp-foundation-professor-artificial-intelligence-medicine-and-founding-director-new-in</guid>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>New collaboration on DNA nanotechnology</title>
      <description><![CDATA[Prof. Chunhai Fan, who is a recipient of the Humboldt Research Award, has been conducting research at the University of Stuttgart since June. Fan works closely with Prof. Laura Na Liu of the 2nd Physics Institute. Both researchers are among the world's leading experts in the field of DNA nanotechnology.]]></description>
      <pubDate>Thu, 10 Sep 2026 08:07:00 +0000</pubDate>
      <link>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-collaboration-dna-nanotechnology</link>
      <guid>https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-collaboration-dna-nanotechnology</guid>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
